Espinoza Octavio bought LGND
December 31, 2025 · Form 4 insider transaction
Espinoza Octavio bought 8 shares of Ligand Pharmaceuticals Incorporated at $95.68 per share, a transaction worth $765.41. The trade was recorded as j and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
8
Price
$95.68
Total value
$765.41
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeJ: J
Transaction dateDecember 31, 2025
Filing dateJanuary 6, 2026
Shares owned after28,575
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).